Jasper Therapeutics, Inc.
JSPR • NASDAQ • Stock Fundamentals
Jasper Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeetinder Singh Mahal, with a market cap of $25.5M.
Market Cap$25.5M
Employees45.0
CEOJeetinder Singh Mahal
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Jasper Therapeutics, Inc. FAQ
Common questions about Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. (JSPR) has a market capitalization of $25.5M and trades on NASDAQ.
Jasper Therapeutics, Inc. has approximately 45 employees.